
ELV Stock Forecast & Price Target
ELV Analyst Ratings
Bulls say
Elevance Health is in a strong financial position, with a positive outlook for growth in its Medicaid and Medicare Advantage plans and the potential for expansion into pharmacy benefit management and other healthcare services. The company's recent acquisitions, strong position as the largest single provider for Blue Cross Blue Shield branded coverage, and diversified coverage plans make it a leader in the health insurance industry. In addition, the company's commitment to diversity within its leadership and workforce, along with its efforts to address social responsibility issues in its communities, make it a strong choice for sustainability-oriented investors. While there may be some concerns about rising costs and potential challenges in the commercial market, we believe Elevance's strong overall performance, growth opportunities, and sound financials make it a solid investment choice.
Bears say
Elevance Health is a leading health insurance company in the US with a unique position as the largest single provider of Blue Cross Blue Shield branded coverage in 14 states. However, the company faces potential risks such as incremental risk pool deterioration in the ACA market, Medicaid cost utilization spikes, and lack of uptake of its Carelon services. While management has a commitment to grow EPS by at least 12% in 2027, there are uncertainties and risks that may hinder this goal. Additionally, the company's 2026 EPS guidance and margin projections are lower compared to previous estimates.
This aggregate rating is based on analysts' research of Elevance Health Inc and is not a guaranteed prediction by Public.com or investment advice.
ELV Analyst Forecast & Price Prediction
Start investing in ELV
Order type
Buy in
Order amount
Est. shares
0 shares